AndroGel Cost in Michigan 2026: Cash Pay, Insurance, Medicaid, and Compounded Alternatives

What Is the Cash-Pay Price of AndroGel in Michigan in 2026?

The retail cash-pay price of AndroGel in Michigan tracks closely with AbbVie's national list price of approximately $510 per month for the 1.62% formulation (75 g pump). Without insurance or a discount program, most Michigan pharmacies including CVS, Walgreens, Meijer, and Rite Aid quote prices in the $490 to $530 range depending on the specific formulation and pack size. That figure has held relatively steady since 2024 and reflects no coupon or savings card applied.

Testosterone itself is a Schedule III controlled substance under the Controlled Substances Act, which means every AndroGel prescription requires a DEA-compliant prescriber and cannot be refilled without a new written or electronic prescription in Michigan. Michigan Public Health Code, MCL 333.7333, mirrors federal rules on Schedule III refills.

The 1% formulation (AndroGel 1%, 50 mg/5 g packets) carries a similar list price per month. Generic testosterone gel 1% is available at several Michigan pharmacies and typically runs $80 to $160 per month cash, making it the cheapest branded-generic option short of compounding. GoodRx and similar platforms list generic testosterone gel 1% at under $90 at select Meijer and Costco locations in metro Detroit and Grand Rapids as of early 2025. Generic substitution for testosterone gel is permitted in Michigan under the state's Drug Product Selection Act.

The T-Trials (Testosterone Trials, N=788 men aged 65 and older), published in the New England Journal of Medicine and indexed at PubMed, confirmed that testosterone gel raised serum testosterone from a mean of 234 ng/dL to 332 ng/dL over 12 months, providing the clinical rationale that drives ongoing prescribing. [1]

How Does Michigan Medicaid Cover AndroGel?

Michigan Medicaid (Healthy Michigan Plan and traditional fee-for-service) covers AndroGel and generic testosterone gel for male hypogonadism, but a prior authorization (PA) request is required before the claim will pay. The PA criteria generally require documentation of two fasting morning serum total testosterone levels below 300 ng/dL drawn at least 30 days apart, a confirmed clinical diagnosis of hypogonadism (ICD-10 E29.1), and confirmation that a secondary cause such as a pituitary adenoma has been assessed. The Endocrine Society's 2018 clinical practice guideline on testosterone therapy recommends this same two-measurement threshold before initiating treatment. [2]

Michigan's Medicaid pharmacy benefit is administered through managed care organizations (MCOs) including Molina Healthcare of Michigan, Priority Health, and McLaren Health Plan. Each MCO maintains its own preferred drug list (PDL). As of 2025, most Michigan Medicaid MCOs list generic testosterone gel 1% as the preferred product, meaning AndroGel brand may require step therapy showing that the generic was tried first or is contraindicated. Prescribers should check the specific MCO's PDL before submitting a PA to avoid delays. CMS guidance on Medicaid PDL requirements is available here.

PA approvals in Michigan Medicaid are typically granted for 12 months and require annual re-authorization with repeat serum testosterone documentation. If a PA is denied, the prescriber may file a formal appeal or switch to a preferred generic under the MCO's formulary. Telehealth visits count toward PA documentation in Michigan since the state enacted permanent telehealth parity legislation in 2022 (PA 148 of 2020, extended). Michigan's telehealth parity rules are summarized by AAFP. [3]

Which Private Insurance Plans Cover AndroGel in Michigan?

Most commercial plans sold in Michigan, including Blue Cross Blue Shield of Michigan, Priority Health commercial, HAP (Health Alliance Plan), and McLaren commercial, place testosterone gel on Tier 2 or Tier 3 of their formulary. A Tier 2 copay with a typical Michigan employer plan runs $30 to $60 per 30-day supply for generic testosterone gel. AndroGel brand at Tier 3 may require a $60 to $120 copay or 25 to 40% coinsurance after deductible. The FDA label for AndroGel 1.62% (NDA 022504) confirms dosing parameters that most plan formularies reference for medical necessity criteria. [4]

High-deductible health plans (HDHPs) are common among Michigan small employers. Under an HDHP, a patient pays full list price until meeting the deductible (often $1,500 to $3,000 per year). That means January through February or March of each year may be full-price months even with insurance, adding $500 or more to out-of-pocket costs before coverage kicks in. Patients on an HDHP who also carry an HSA can pay for AndroGel or generic testosterone gel with pre-tax dollars, which reduces the effective cost by their marginal tax rate. IRS Publication 502 confirms testosterone therapy for hypogonadism is a qualified medical expense.

Medicare Part D covers testosterone gel for Medicare-eligible Michigan residents diagnosed with hypogonadism. The specific tier placement varies by plan (AARP/UnitedHealthcare, Humana, Blue Cross Medicare, etc.), but generic testosterone gel 1% typically falls on Tier 1 or 2 under most Part D plans. CMS provides Medicare Part D formulary lookup tools at medicare.gov.

How Does the AbbVie Savings Card and myAbbVie Assist Program Work in Michigan?

AbbVie operates two separate financial assistance programs for AndroGel that apply in Michigan, and confusing them is a common and costly mistake. The myAbbVie Assist copay card targets commercially insured patients (including BCBS of Michigan and Priority Health commercial) and may reduce the out-of-pocket cost to as low as $0 per month, depending on plan tier and deductible status. AbbVie's patient assistance information is published at fda.gov-referenced prescribing information sources and at abbvie.com. [5]

The myAbbVie Assist patient assistance program (PAP) is separate and targets uninsured or underinsured patients who meet income thresholds, generally at or below 400% of the federal poverty level. Michigan residents who qualify may receive AndroGel at no cost through this program. Applications require proof of Michigan residency, income verification, and a prescription from a licensed Michigan prescriber.

Neither program is available to patients whose primary coverage is a federal or state government program, meaning Michigan Medicaid, Medicare Part D, or CHIP patients cannot use the AbbVie copay card. That restriction is standard across manufacturer copay cards and stems from the federal anti-kickback statute. The OIG's guidance on manufacturer copay cards and federal program exclusions is here. [6]

To enroll, a Michigan patient or their prescriber contacts AbbVie directly via the AbbVie website or by phone. Enrollment takes 10 to 15 minutes and the card activates within 24 to 48 hours. The savings card is presented at the pharmacy (or entered for mail-order) each month.

Is Compounded Testosterone Gel Legal in Michigan?

Compounded testosterone gel is legal in Michigan when prepared by a state-licensed 503A pharmacy and dispensed based on a valid patient-specific prescription from a Michigan-licensed prescriber. The 503A designation comes from Section 503A of the Federal Food, Drug, and Cosmetic Act, which governs traditional compounding pharmacies that prepare medications for individual patients. The FDA's 503A compounding framework is explained at FDA.gov. [7]

Michigan's Board of Pharmacy licenses compounding pharmacies under MCL 333.17748 and requires that they comply with USP Chapter 795 standards for non-sterile preparations. Testosterone gel is a non-sterile topical preparation and falls under USP 795 rather than USP 797 (which governs sterile preparations). USP 795 standards are referenced by the FDA in guidance documents here. [8]

Compounded testosterone gel in Michigan typically runs $80 to $120 per month for a 30-day supply of 1% gel (50 mg/day dose), compared to the $510 list price for brand AndroGel. That cost difference is real. Several telehealth platforms operating legally in Michigan (HealthRX included) route testosterone prescriptions to licensed 503A compounding pharmacies when a patient lacks insurance coverage or carries a high deductible.

One practical caveat: compounded testosterone is not FDA-approved and lacks the bioequivalence data that the branded product carries. The Endocrine Society's 2018 guideline states, "We suggest using FDA-approved testosterone preparations rather than compounded formulations when FDA-approved products are available and affordable." [2] That guidance is reasonable when cost is manageable. When cost is a genuine barrier to treatment, a compounded preparation at a licensed Michigan 503A pharmacy is a legally and clinically defensible option, provided the prescriber documents the rationale.

503B outsourcing facilities (which produce large batches without patient-specific prescriptions) are not legally permitted to compound testosterone for office stock under current FDA policy, because testosterone is not on the FDA's 503B drug shortage list. Michigan patients should confirm their pharmacy holds 503A (not 503B) status before filling a compounded testosterone order. FDA's list of registered 503B outsourcing facilities is searchable here. [9]

Can Michigan Patients Get AndroGel or Testosterone Gel via Telehealth?

Yes. Michigan permits telehealth prescribing of testosterone gel for male hypogonadism, provided the prescriber follows Michigan's telehealth prescribing standards and the Ryan Haight Online Pharmacy Consumer Protection Act requirements for controlled substances. The DEA's telemedicine and controlled substance prescribing rules are posted at the DEA Diversion Control Division site. [10]

The Ryan Haight Act generally requires an in-person evaluation before a controlled substance (including testosterone, a Schedule III substance) can be prescribed via telemedicine. However, the DEA issued a proposed rule in 2023 that would expand telemedicine prescribing of Schedule III substances without a prior in-person visit under specific conditions. As of early 2025, the temporary COVID-era telemedicine flexibilities that allowed first-time Schedule III prescribing via audio-visual platforms have been extended on a rolling basis. Michigan prescribers operating within a telemedicine platform registered with the DEA may prescribe testosterone gel to new patients via synchronous audio-visual visits while those flexibilities remain active. Current DEA telemedicine guidance is here. [11]

From a Michigan state law standpoint, PA 148 of 2020 established permanent telehealth parity for Medicaid, and Michigan's medical licensing board permits telehealth diagnosis and prescribing for established or new patients as long as the standard of care is met. A telehealth visit generating a testosterone prescription must include symptom documentation, review of two morning serum testosterone lab values, and consideration of secondary causes, the same steps required in an in-person visit. The Michigan Department of Licensing and Regulatory Affairs (LARA) guidelines for telehealth are consistent with AAFP recommendations. [3]

What Is the Cheapest Way to Get Testosterone Gel in Michigan?

The lowest reliable monthly cost path depends on insurance status. This framework outlines the four main scenarios Michigan patients face in 2026.

Scenario 1. Commercially insured, AndroGel brand preferred or allowed. Apply the AbbVie myAbbVie Assist copay card. Monthly cost may drop to $0 or a small fixed copay. Total annual exposure: $0 to $240.

Scenario 2. Commercially insured, high deductible or brand not preferred. Ask the prescriber to switch to generic testosterone gel 1%. Generic is on most Michigan plan Tier 1 or 2. Monthly copay: $15 to $60. Use GoodRx or a similar coupon at Meijer or Costco if the coupon beats the insurance price for generic.

Scenario 3. Uninsured or underinsured. Two options. First, apply for myAbbVie Assist PAP (income-based, may provide brand AndroGel free). Second, obtain a prescription for compounded testosterone gel 1% from a licensed Michigan 503A pharmacy. Cost: $80 to $120 per month. Telehealth visit cost adds $50 to $150 for the initial consultation depending on platform.

Scenario 4. Michigan Medicaid. Work with the prescriber to submit a PA. If approved for generic testosterone gel (the preferred product on most MCO PDLs), out-of-pocket cost is $1 to $3 per prescription under Medicaid co-pay rules. If the PA is denied, appeal or request generic substitution. Cost with approved PA: under $5 per month.

A 2023 analysis in JAMA Internal Medicine found that cash-pay prices for common generic drugs at Costco and Walmart were lower than insurance copays in 23% of cases examined. [12] That finding applies here: Michigan patients with HDHPs who are pre-deductible should always compare the GoodRx cash price for generic testosterone gel 1% against their plan's deductible rate before paying full price.

The T-Trials also demonstrated that sexual function, bone mineral density, and mood outcomes improved meaningfully over 12 months of testosterone treatment in hypogonadal men, reinforcing that cost barriers resulting in non-adherence carry real clinical consequences. [1] A serum total testosterone target of 400 to 700 ng/dL is recommended by the Endocrine Society for most hypogonadal men on gel therapy, and maintaining consistent daily application is required to stay within that range. [2]

How Do Michigan Pharmacy Prices Compare Across Chains?

Retail prices for AndroGel and generic testosterone gel vary by pharmacy in Michigan even at the same cash-pay rate, because each chain negotiates different base prices with AbbVie and generic manufacturers. Based on publicly available GoodRx data from early 2025, generic testosterone gel 1% (50 g tube, equivalent to roughly one month of 5 g/day dosing) ranges from approximately $48 at Costco Wholesale (Ann Arbor, Grand Rapids) to $160 at independent pharmacies. Walgreens and CVS typically quote $130 to $160 for the same product without a coupon. Meijer Pharmacy, which is Michigan-based and commonly used in mid-Michigan and West Michigan, frequently offers prices near $70 to $90 for generic testosterone gel with a GoodRx coupon. GoodRx pricing methodology and sources are described here.

For brand AndroGel 1.62% (60.75 g pump, 75 actuations), cash prices at Michigan chains without any discount card run $495 to $530. The AbbVie copay card or GoodRx coupon (whichever applies to the patient's situation) should be applied before paying. Patients using mail-order pharmacy through their Michigan insurance plan often receive a 90-day supply at two times the monthly copay, saving one month's cost per quarter. FDA drug pricing transparency resources are available at FDA.gov. [13]

Understanding the Endocrine Society Guidelines That Drive PA Decisions in Michigan

Michigan Medicaid MCOs and most commercial payers in Michigan anchor their prior authorization criteria to the Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy. That document, authored by Shalender Bhasin and colleagues, states: "We recommend making a diagnosis of hypogonadism only in men with consistent symptoms and signs and unequivocally low serum testosterone levels." [2] Most Michigan payers operationalize "unequivocally low" as two fasting morning total testosterone values below 300 ng/dL. The full Endocrine Society guideline is indexed on PubMed here. [2]

Free testosterone measurement adds diagnostic precision when sex hormone-binding globulin (SHBG) is elevated, a common finding in older Michigan patients with metabolic syndrome or obesity. A total testosterone between 300 and 400 ng/dL with a low free testosterone (below 65 pg/mL by equilibrium dialysis) may still satisfy PA criteria if the prescriber documents the SHBG level and free testosterone result. Free testosterone measurement methodology is reviewed in the Journal of Clinical Endocrinology and Metabolism. [14]

The Endocrine Society guideline explicitly advises against testosterone therapy in men with prostate cancer, breast cancer, unevaluated prostate nodule, hematocrit above 54%, severe lower urinary tract symptoms, uncontrolled heart failure, or planned fertility in the near term. Payers in Michigan use this contraindication list as exclusion criteria in PA forms. Submitting a PA that documents ruling out these contraindications speeds approval and reduces the chance of an automatic denial. The FDA's 2015 label change requiring cardiovascular risk communication is here. [4]

The T-Trials (N=788, NEJM 2016) tested transdermal testosterone gel in men aged 65 and older with total testosterone below 275 ng/dL and found that sexual function scores improved by 0.58 points on the PDAS (P<0.001) and bone mineral density increased significantly in the spine and hip at 12 months. [1] These findings are frequently cited by prescribers in PA letters to justify the clinical necessity of ongoing treatment in older Michigan men.

Michigan-Specific Resources for AndroGel Patients

Michigan residents seeking help with AndroGel costs have access to several state-level resources beyond national programs. The Michigan Department of Health and Human Services (MDHHS) operates the MI Bridges portal, which screens for Medicaid eligibility in real time and can fast-track Healthy Michigan Plan enrollment for uninsured patients. MI Bridges information from MDHHS is here. Patients who qualify for Medicaid after a telehealth diagnosis of hypogonadism can transition their prescription to Medicaid billing within 30 to 60 days of enrollment, retroactively covering up to 90 days of prior claims in some MCO agreements.

The Michigan Prescription Drug Affordability Board (PDAB) began operations in 2024 following PA 11 of 2023. Its mandate covers upper payment limits on selected high-cost drugs, though testosterone gel has not been selected as a target drug as of early 2025. Patients can follow PDAB proceedings at the MDHHS website for future developments. FDA transparency in drug pricing is addressed in federal guidance here. [13]

NeedyMeds and the Partnership for Prescription Assistance (PPA) also maintain databases of Michigan-based patient assistance programs. Both are free to use and may identify additional local resources, particularly for patients in rural Upper Peninsula or northern Lower Peninsula communities where access to in-person endocrinology is limited and telehealth is the primary prescribing pathway. NIH resources on testosterone deficiency and treatment options are available at MedlinePlus. [15]

For patients who receive a testosterone prescription through a telehealth platform and ship to a Michigan address, the compounding pharmacy must hold a Michigan pharmacy license in addition to its home state license (or hold a non-resident pharmacy license issued by the Michigan Board of Pharmacy). Confirming this license status takes two minutes on the LARA license lookup tool and prevents receiving an unlicensed compound. Michigan LARA license verification is available at lara.michigan.gov. [16]

A morning serum total testosterone drawn between 7 a.m. and 10 a.m., fasting, at least two hours after applying AndroGel, remains the standard monitoring test in Michigan and nationally, per Endocrine Society guidance. [2]